References
- American College of Obstetricians and Gynecologists. Task force on hypertension in pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013;122:1122–31
- Lisonkova S, Sabr Y, Mayer C, et al Maternal morbidity associated with early-onset and late-onset preeclampsia. Obstet Gynecol 2014;124:771–81
- Holobotovskyy V, Chong YS, Burchell J, et al Regulator of G protein signaling 5 is a determinant of gestational hypertension and preeclampsia. Sci Transl Med 2015;7:290ra88
- Ghosh SK, Raheja S, Tuli A, et al Serum PLGF as a potential biomarker for predicting the onset of preeclampsia. Arch Gynecol Obstet 2012;285:417–22
- Chaiworapongsa T, Romero R, Gotsch F, et al Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age. J Matern Fetal Neonatal Med 2008;21:41–52
- Sibai B, Romero R, Klebanoff MA, et al Maternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia. Am J Obstet Gynecol 2009;200:630.e631–8
- Romero R, Kusanovic JP, Than NG, et al First-trimester maternal serum PP13 in the risk assessment for preeclampsia. Am J Obstet Gynecol 2008;199:122.e1–11
- Buhimschi IA, Nayeri UA, Zhao G, et al Protein misfolding, congophilia, oligomerization, and defective amyloid processing in preeclampsia. Sci Transl Med 2014;6:245ra92
- Hu WT, Li MQ, Liu W, et al IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-Kb and ERK1/2 signaling. Mol Hum Reprod 2014;20:358–72
- Demircan K, Cömertoğlu İ, Akyol S, et al A new biological marker candidate in female reproductive system diseases: matrix metalloproteinase with thrombospondin motifs (ADAMTS). J Turk Ger Gynecol Assoc 2014;15:250–5
- St.Whitley GJ, Cartwright JE. Cellular and molecular regulation of spiral artery remodelling: lessons from the cardiovascular field. Placenta 2010;31:465–74
- Lee SY, Lee HS, Gil M, et al Differential expression patterns of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) -1, -4, -5, and -14 in human placenta and gestational trophoblastic diseases. Arch Pathol Lab Med 2014;138:643–50
- Abbaszade I, Liu RQ, Yang F, et al Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem 1999;274:23443–50
- Hurskainen T, Hirohata S, Seldin MF, Apte SS. ADAM-TS5, ADAM-TS6, and ADAM-TS7, novel members of a new family of zinc metalloproteases. General features and genomic distribution of the ADAM-TS family. J Biol Chem 1999;274:25555–63
- Llamazares M, Cal S, Quesada V, López-Otín C. Identification and characterization of ADAMTS-20 defines a novel subfamily of metalloproteinases-disintegrins with multiple thrombospondin-1 repeats and a unique GON domain. J Biol Chem 2003;278:13382–9
- Somerville RP, Longpre JM, Jungers KA, et al Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1. J Biol Chem 2003;278:9503–13
- Somerville RP, Jungers KA, Apte SS. Discovery and characterization of a novel, widely expressed metalloprotease, ADAMTS10 and its proteolytic activation. J Biol Chem 2004;279:51208–17
- Granne I, Southcombe JH, Snider JV, et al ST2 and IL-33 in pregnancy and pre-eclampsia.. PLoS ONE 2011;6:e24463
- Komai-Koma M, Xu D, Li Y, et al IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol 2007;37:2779–86
- Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003;69:1–7
- Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 2006;27:939–58
- Beristain AG, Zhu H, Leung PC. Regulated expression of ADAMTS-12 in human trophoblastic cells: a role for ADAMTS-12 in epithelial cell invasion? PLoS One 2011;6:e18473
- Cunningham FG. Hypertensive disorders. In: Gary Cunningham F, Kenneth JL, Steven LB, et al, eds. Williams obstetrics. 24th ed. New York (NY): McGraw-Hill; 2014;728–79
- Laigaard J, Sørensen T, Placing S, et al Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia. Obstet Gynecol 2005;106:144–9
- Stampalija T, Chaiworapongsa T, Romero R, et al Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia. J Matern Fetal Neonatal Med 2013;26:1359–70